-+ 0.00%
-+ 0.00%
-+ 0.00%

PHIO PHARMACEUTICALS CORP: SAFETY DATA THROUGH EXTENDED FOLLOW-UP PERIOD IS EXPECTED TO BE REPORTED IN Q2 OF 2026

Reuters·01/20/2026 14:33:59

Please log in to view news